Free Account Opening + AMC Free Demat
Loading...

Au Financiers IPO vs Eris Lifesciences IPO

Comparision between Au Financiers IPO and Eris Lifesciences IPO.

IPO Details

Au Financiers IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Eris Lifesciences IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

Issue Size and Price

The total issue size of Au Financiers IPO is up to ₹1,912.51 Cr whereas the issue size of the Eris Lifesciences IPO is up to ₹1,741.16 Cr. The final issue price of Au Financiers IPO is ₹358.00 per share and of Eris Lifesciences IPO is ₹603.00 per share.

  Au Financiers IPO Eris Lifesciences IPO
Face Value ₹10 per share ₹1 per share
Issue Price (Lower) ₹355.00 per share ₹600.00 per share
Issue Price (Upper) ₹358.00 per share ₹603.00 per share
Issue Price (Final) ₹358.00 per share ₹603.00 per share
Discount (Retail)
Discount (Employee) ₹60.00 per share
Market Lot Size 41 shares 24 shares
Fresh Issue Size
Fresh Issue Size (Amount)
OFS Issue Size 5,34,22,169 shares 2,88,75,000 shares
OFS Issue Size (Amount)
Issue Size Total 2,88,75,000 shares
Issue Size Total (Amount) up to ₹1,912.51 Cr up to ₹1,741.16 Cr

IPO Timetable

Au Financiers IPO opens on Jun 28, 2017, while Eris Lifesciences IPO opens on Jun 16, 2017. The closing date of Au Financiers IPO and Eris Lifesciences IPO is Jun 30, 2017, and Jun 20, 2017, respectively.

  Au Financiers IPO Eris Lifesciences IPO
Anchor Bid Date
Issue Open Jun 28, 2017 Jun 16, 2017
Issue Close Jun 30, 2017 Jun 20, 2017
Basis Of Allotment (Tentative) Jul 05, 2017 Jun 23, 2017
Initiation of Refunds (Tentative) Jul 06, 2017 Jun 27, 2017
Credit of Share (Tentative) Jul 07, 2017 Jun 28, 2017
Listing date (Tentative) Jul 10, 2017 Jun 29, 2017
Anchor Lockin End date 1 Aug 04, 2017 Jul 23, 2017
Anchor Lockin End date 2 Oct 03, 2017 Sep 21, 2017

Financials

Au Financiers IPO P/E ratio is , as compared to Eris Lifesciences IPO P/E ratio of .

  Au Financiers IPO Eris Lifesciences IPO
Financial
Summary of financial Information (Consolidated)
Particulars For the year/period ended (in Rs. Million)
31-Mar-17 31-Mar-16 31-Mar-15 31-Mar-14 31-Mar-13
Total Assets 98,176.41 62,730.09 39,799.04 29,585.91 31,128.10
Total Revenue 14,305.21 10,519.50 6,894.08 5,713.20 4,130.84
Profit After Tax 8,427.13 2,471.54 1,394.50 725.40 693.58
Summary of financial Information (Consolidated)
Particulars For the year/period ended (in Rs. Million)
31-Mar-16 31-Mar-15 31-Mar-14 31-Mar-13 31-Mar-12
Total Assets 3,973.59 3,572.85 2,705.99 1,718.05 1,019.67
Total Revenue 5,970.21 5,455.58 5,088.22 3,930.64 2,739.40
Profit After Tax 1,348.58 892.59 709.12 584.40 370.63
Promoter Shareholding (Pre-Issue)
Promoter Shareholding (Post-Issue)
P/E Ratio
Market Cap
ROE
ROCE
Debt/Equity
EPS
RoNW

Shares Offered

In the Au Financiers IPO retail investors (RII) are offered 1,83,47,760 shares while in Eris Lifesciences IPO retail investors are offered 1,83,47,760 shares. Qualified institutional buyers (QIB) are offered 1,04,84,434 shares in Au Financiers IPO and 86,17,500 shares in Eris Lifesciences IPO.

  Au Financiers IPO Eris Lifesciences IPO
Anchor Investor Reserveration
Market Maker Reserveration
QIB 1,04,84,434 shares 86,17,500 shares
NII 78,63,326 shares 43,08,750 shares
RII 1,83,47,760 shares 28,72,500 shares
Employee 10,00,000 shares 1,50,000 shares
Others
Total 3,76,95,520 shares 1,59,48,750 shares

Bids Received (Subscription)

Au Financiers IPO subscribed 53.60x in total, whereas Eris Lifesciences IPO subscribed 3.29x.

  Au Financiers IPO Eris Lifesciences IPO
QIB (times) 78.77x 4.68x
NII (times) 143.51x 0.45x
Big NII (times)
Small NII (times)
RII (times) 3.52x 3.51x
Employee (times) 1.45x 0.86x
Other (times)
Total (times) 53.60x 3.29x

Comments

Add a public comment...